Leveling up Pharmacist Care in Ontario with Dr. Mina Tadrous

Can your local pharmacist help fix the primary care crisis?  Dr. Mina Tadrous, host of I’m Pharmacy, joins us to explore the data behind expanded pharmacy services in Ontario — and what this shift means for the future of healthcare. A note that this episode was recorded during the Ontario provincial election. We also make mention of a few acronyms:UTI: Urinary tract infectionPPIs: Proton pump inhibitors are a class of medications that reduce stomach acid.ODPRN: Ontario Drug Policy Research NetworkInspire-PHC: Inspire – Primary Health Care supports Ontario researchers with all aspects of their projects related to primary care.Our Guest:Mina is an assistant professor at the Leslie Dan Faculty of Pharmacy at the University of Toronto and the Tier 2 Canada Research Chair in Pharmaceutical Policy and Real-world Evidence. He is also co-director of Pharmaceutical Policy and Pharmacy Practice at the Ontario Drug Policy Research Network (ODPRN) and ICES adjunct scientist. Mina leads research focused on evaluating drug policies and post-marketing surveillance of medications. He works closely with policymakers and uses large data sets to answer questions about real-world safety and effectiveness and improving the optimal use of medications.Check out Mina’s podcast:https://www.pharmacy.utoronto.ca/about/im-pharmacy-podcast-season-fourRead the Research:Impact of the COVID-19 Controlled Drugs and Substances Act exemption on pharmacist prescribing of opioids, benzodiazepines and stimulants in Ontario: a cross-sectional time-series analysisApplied Health Research Question (AHRQ) Project (in progress): Evaluating pharmacist scope of practice expansion EPISODE CREDITS:Produced, edited and mixed by Will Mcintyre, Richard Villeneuve and Pop Up PodcastingArtwork designed by Stella-Luna HaMusic licensed through Melodie MusicLINKS:Be sure to follow and tag ICES on Facebook, Instagram and LinkedIn. To find out more about our organization, visit us at ices.on.ca